Development of polysaccharide-capped niosomes for oral immunization of tetanus toxoid

Journal of Drug Delivery Science and Technology

Volumn 16, Issue 3, 2006, Pages 167-172

  Katare, R ^a   Gupta, P M ^b   Mahor, S ^b   Rawat, A ^b   Khatri, K ^b   Katare, Y ^a   Panda, A K ^a   Vyas, S P ^b  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b DR H S GOUR UNIVERSITY   (India)

Author keywords

Niosomes; Oral vaccines; Polysaccharides; Tetanus toxoid; Vesicular carriers

Indexed keywords

ALUMINUM POTASSIUM SULFATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; NIOSOME; O PALMITOYLPULLULAN; POLYSACCHARIDE; PULLULAN; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG SYNTHESIS; ENCAPSULATION; EVAPORATION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; INFRARED SPECTROSCOPY; INTESTINE FLUID; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PH; PROTON NUCLEAR MAGNETIC RESONANCE; STOMACH JUICE; TETANUS; VAGINA SECRETION;

EID: 33745449476     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(06)50031-0     Document Type: Article

References (36)

1. SHALABY W.S. - Development of oral vaccines to stimulate mucosal and systemic immunity: barriers and novel strategies. - Clin. Immunol. Immunopathol., 74 (2), 127-134, 1995.
2. KAGNOFF F.M. - Immunology of the intestinal tract. - Gastroenterology, 105, 1275-1280, 1993.
3. CRIPPS W.A., KYD M.J., FOXWELL R.A.-Vaccines and mucosal immunization. -Vaccine, 19, 2513-2515, 2000.
4. JONES-RUSSELL J.G. - Oral vaccine delivery. - J. Control. Release, 65, 49-54, 2000.
5. MESTECKEY J. -The common mucosal immune system and current strategies for induction of immune responses in external secretions. - J Clin. Immunol., 7, 265-276, 1987.
6. GUTIERRO I., HERNANDEZ R.M., IGARTUA M., GASCON A.R. PEDRAZ J.L. - Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded microspheres. - Vaccine, 21, 67-77, 2002.
7. KATZ D.E., DELORIMIER A.J., WOLF M.K., HALL E.R., CASSELS F.J., VAN HAMONT J.E., NEWCOMWER R.L., DAVACHI M.A., TAYLOR D.N., MCQUEEN C.E.-Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) C56 antigen. - Vaccine, 21, 341-346, 2003.
8. YEH M.K., LIU Y.T., CHEN J.L., CHIANG C.H. - Oral immunogenicity of the inactivated vibrio cholera whole cell vaccine encapsulated in biodegradable microparticles. - J Control Release, 82, 237-247, 2002.
9. CHEN H., TORCHILIN V., LANGER R.-Lectin-bearing polymerized liposomes as potential oral vaccine carriers. - Pharm Res, 13(9), 1378-83, 1996.
10. BOWERSOCK T.L., HOGENESCH H., SUCKOW M., PORTER R.E., JACKSON R., PARK H., PARK K. - Oral vaccination with alginate microsphere systems. - J Control Release, 31, 209-220, 1996.
11. BOWERSOCK T.L., HOGENESCH H., SUCKOW M., GUIMOND P., MARTIN S., BORIE D., TORREGROSA S., PARK H. PARK K. - Oral vaccination of animal with antigens encapsulated in alginate microspheres. - Vaccine, 17, 1804-1811, 1999.
12. CHO N.H., SEONG S.Y., CHUN K.H., KIM Y.H., KWON I.C., AHN B.Y., JEONG S.Y. - Novel mucosal immunization with polysaccharide-protein conjugates entrapped in alginate microspheres. - J. Control Release, 53 (1-3), 215-224, 1998.
13. SANTIAGO N., MILSTEIN S., RIVERA T., GARCIA E., ZAIDI T., HONG H., BUCHER D. - Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens. - Pharm. Res, 10, 1243-1247, 1993.
14. CONACHER M., ALEXANDER J., BREWER J.M. - Oral immunization with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). - Vaccine, 19, 2965-2974, 2001.
15. SINGH P., PRABHAKARAN D., JAIN S., MISHRA V., JAGANATHAN K.S., VYAS S.P. Cholera toxin B conjugated bile salt stabilized vesicles (bilosomes) for oral immunization. - Int J Pharm, 278, 379-390, 2004.
16. BREWER J.M., ALEXANDER J. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. - Immunology, 75 (4), 570-575, 1992.
17. GUPTA R.K., VARANELLI C.L., GRIFFIN P., WALLACH D.F.H., SIBER G.R.-Adjuvant properties of non phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. - Vaccine, 14, 219-225, 1996.
18. VENKATESAN N., VYAS S.P. - Polysachharide coated liposomes for oral immunization - development and characterization. - Int. J. Pharm., 203, 169-177, 2000.
19. JAIN S., SINGH P., MISHRA V., VYAS S.P. - Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. - Immunol Lett., 101, 41-49, 2005.
20. LASIC D.D. - On the thermodynamic stability of liposomes. - J Colloid Interface Sci, 140, 302-304, 1990.
21. LESIEUR S., GRABIELLEMADELMONT C., PATERNOSTRE M.T., MOREAU J.M., HANDJANI-VILA R.M., OLLIVON M. - Action of octylglucoside on non-ionic monoalkyl amphiphile-cholesterol vesicles-study of the solubilization mechanism. - Chem. Phys. Lipids, 56, 109-121, 1990.
22. UCHEGBU I.F., VYAS S.P. - Non-ionic surfactant-based vesicles (niosomes) in drug delivery. - Int. J. Pharm., 172, 33-70, 1998.
23. UCHEGBU I.F., MCCARTHY D., SCHATZLEIN, A., FLORENCE, A.T. - Phase-transitions in aqueous dispersions of the hexadecyl diglycerol ether (c(16)g(2)) non-ionic surfactant, cholesterol and cholesteryl poly-24-oxyethylene ether-vesicles, tubules, discomes and micelles. - STP Pharm. Sci., 6, 33-43, 1996.
24. SUNAMOTO J., IWAMOTO K. - Protein anchored and polysaccharide anchored liposomes as a drug carrier. - CRC Crit. Rev. Then Drug Carrier Syst., 2, 117-136, 1986.
25. SIHORKAR V., VYASS. P. - Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. - J. Pharm. Pharm. Sci., 4, 138-158, 2001.
26. SUNAMOTO J., SATO T., TAGUCHI T., HAMAZAKI H.-Naturally occurring polysaccharide derivatives which behave as in artificial cell wall on an artificial cell liposomes. - Macromolecules, 25, 5665-5670, 1992.
27. SZOKA F., PAPAHADJOPOULOS D. - Procedure for preparation of liposomes with large aqueous space and high capture by reverse phase evaporation. - Proc. Natl. Acad. Sci. USA., 75, 4194-4198, 1978.
28. SUNAMOTO J., SATO T., HIROTA M., FUKISHIMA K., HIRATANI K., HARA K. - A newly developed immnoliposomes: an egg phosphatidylcholine liposomes coated with pullulan bearing both a cholesterol moiety and an IgMs fragment. - Biochim. Biophys. Acta., 898, 323-330, 1987.
29. FRY D.W., WHITE J.C., GOLDMAN I.D. - Rapid separation of low molecular weight solids from liposomes without dilution. - Anal. Biochem., 90, 809-815, 1978.
30. ELSON C.O., EALDING W., LEFKOWITZ J.-A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. - J. Immunol. Methods, 67, 101-108, 1984.
31. SATO T., SUNAMOTO J. - Recent aspects in the use of liposomes in biotechnology and medicine. - Prog. Lipid Res., 31, 345-372, 1992.
32. PAVIA D.L., LAMPMAN G.M., CRAZE G.S. - Infrared absorption process. - In: Introduction to spectroscopy: a guide for students of organic chemistry, R.W. HOLT Eds. Saunder College, Philadelphia, 1979, pp.13-15.
33. MOREIRA J.N., ALMEIDA L.M., GERALDES C.F., MADEIRA V.M.C., COSTA M.L. - Carboplatin liposomes anchored with O-palmitoyl pullulan: In vitro characterization. - Int. J. Pharm., 147, 153-164, 1997.
34. AKIYOSHI K., DEGUCHI S., MORIGUCHI N., YAMAGUCHI S., SUNAMOTO J. - Self aggregates of hydrophobized polysachharides in water: Formation and characteristics of nanoparticles. - Macromolecules, 26, 3062-3068, 1990.
35. TABATA Y., INOUE Y., IKADA Y. - Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. - Vaccine, 14, 1677-1685, 1996.
36. LAVELLE E.C., SHARIF S., THOMAS N.W., HOLLAND J., DAVIS S.S. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. - Adv. Drug Del. Rev., 18, 5-22, 1995.